Christy Covington, APRN
Gerontology · Oklahoma City, OKNPI 1538824818
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.8% of the total across 570 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AstraZeneca at 26.9% of the total. 2025 is the largest year on record at $3,915, 3.1 times the $1,280 reported in 2022. Among gerontology clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 570 payments — averaging $20.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- GSK$1K
- Boehringer Ingelheim$1K
- Mylan Specialty L.p.$652
- Jazz Pharmaceuticals Inc.$574
- United Therapeutics Corporation$511
- plus $4K from 19 others
What the payments were for
- Food & beverage$11,28496%
- Education$4944%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 110 | $3,173 |
| GSK | 89 | $1,438 |
| Boehringer Ingelheim | 43 | $1,009 |
| Mylan Specialty L.p. | 52 | $652 |
| Jazz Pharmaceuticals Inc. | 14 | $574 |
| United Therapeutics Corporation | 22 | $511 |
| Amgen | 27 | $501 |
| Sanofi | 26 | $499 |
| Insmed, Inc. | 23 | $480 |
| Regeneron Healthcare Solutions, Inc. | 33 | $441 |
| Harmony Biosciences LLC | 19 | $386 |
| Actelion Pharmaceuticals US, Inc. | 9 | $372 |
| Baxter Healthcare | 16 | $297 |
| Verona Pharma, Inc. | 19 | $225 |
| Philips North America LLC | 15 | $221 |
| Pulmonx Corporation | 5 | $219 |
| Viatris Specialty LLC | 16 | $208 |
| Inogen, Inc. | 12 | $158 |
| Axsome Therapeutics, Inc. | 7 | $120 |
| Sanofi-aventis U.S. LLC | 3 | $101 |
| Merck | 4 | $78 |
| Lilly USA, LLC | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| 3b Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,778 in reported general payments places this provider in the 95th percentile of 73 gerontology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 13 | $162,665 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 110 | $137,023 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 67 | $77,772 |
| Breo ElliptaFluticasone/Vilanterol | 68 | $57,601 |
| Spiriva RespimatTiotropium Bromide | 67 | $57,192 |
| Advair HfaFluticasone Propion/Salmeterol | 28 | $16,463 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 18 | $13,263 |
| SymbicortBudesonide/Formoterol Fumarate | 35 | $11,629 |
| Incruse ElliptaUmeclidinium Bromide | 24 | $10,785 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 287 | $10,243 |
| Montelukast Sodium | 376 | $6,958 |
| Ipratropium Bromide | 183 | $6,457 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 11 | $5,628 |
| Roflumilast | 20 | $4,618 |
| Ventolin HfaAlbuterol Sulfate | 45 | $4,117 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat, Combivent Respimat | $1,009 | $238,748109 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $1,438 | $205,409202 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $3,173 | $89,402102 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 73 gerontology providers in Oklahoma.
Other gerontology in Oklahoma City
- Whitney SimmonsOklahoma City$40K
- Stacie HanesOklahoma City$6K
- Christine ReithOklahoma City$5K
- Ashley NixOklahoma City$4K
- Anita BhandariOklahoma City$4K
- Hannah GoodspeedOklahoma City$3K
- Blaine WhitsonOklahoma City$2K
- Amber GarretsonOklahoma City$1K
- Mildred TwumOklahoma City$952
- Bart BurdickOklahoma City$938
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.